Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ImmunoPrecise Antibodies Ltd. (IPA : NSDQ)
 
 • Company Description   
ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.

Number of Employees: 101

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.31 Daily Weekly Monthly
20 Day Moving Average: 4,797,161 shares
Shares Outstanding: 45.76 (millions)
Market Capitalization: $59.95 (millions)
Beta: 0.44
52 Week High: $1.31
52 Week Low: $0.27
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 94.82% 86.17%
12 Week 203.73% 159.43%
Year To Date 218.19% 198.04%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3204-4464 Markham Street
-
Victoria,A1 V8Z 7X8
CAN
ph: 250-483-0308
fax: -
investors@immunoprecise.com http://www.immunoprecise.com
 
 • General Corporate Information   
Officers
Jennifer Bath - President and Chief Executive Officer
Mitch Levine - Chairman of the Board
Kristin Taylor - Chief Financial Officer
Chris Buyse - Director
Barry A.Springer - Director

Peer Information
ImmunoPrecise Antibodies Ltd. (HLIS)
ImmunoPrecise Antibodies Ltd. (AZTA)
ImmunoPrecise Antibodies Ltd. (APYI)
ImmunoPrecise Antibodies Ltd. (RNVA)
ImmunoPrecise Antibodies Ltd. (HMSY)
ImmunoPrecise Antibodies Ltd. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 45257F200
SIC: 2834
Fiscal Year
Fiscal Year End: April
Last Reported Quarter: 01/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 45.76
Most Recent Split Date: (:1)
Beta: 0.44
Market Capitalization: $59.95 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.08 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.30
Price/Cash Flow: -
Price / Sales: 3.44
EPS Growth
vs. Year Ago Period: 25.00%
vs. Previous Quarter: 14.29%
Sales Growth
vs. Year Ago Period: -5.97%
vs. Previous Quarter: -3.50%
ROE
04/30/25 - -
01/31/25 - -88.87
10/31/24 - -73.74
ROA
04/30/25 - -
01/31/25 - -49.26
10/31/24 - -42.68
Current Ratio
04/30/25 - -
01/31/25 - 2.32
10/31/24 - 1.01
Quick Ratio
04/30/25 - -
01/31/25 - 2.11
10/31/24 - 0.85
Operating Margin
04/30/25 - -
01/31/25 - -115.69
10/31/24 - -114.50
Net Margin
04/30/25 - -
01/31/25 - -190.76
10/31/24 - -114.50
Pre-Tax Margin
04/30/25 - -
01/31/25 - -211.85
10/31/24 - -125.51
Book Value
04/30/25 - -
01/31/25 - 0.57
10/31/24 - 0.83
Inventory Turnover
04/30/25 - -
01/31/25 - 5.94
10/31/24 - 5.59
Debt-to-Equity
04/30/25 - -
01/31/25 - 0.45
10/31/24 - 0.36
Debt-to-Capital
04/30/25 - -
01/31/25 - 30.91
10/31/24 - 26.31
 

Powered by Zacks Investment Research ©